Milwaukee, WI (PRWEB) March 18, 2014
Over the years, doctors have understood the importance of diabetes research and vital insights have been gained through extensive study. With diabetes more prevalent than ever, researchers at the Medical College of Wisconsin have launched several studies related to the complications of Type 2 diabetes.
With detailed information gathered, the focus of the latest Medical College of Wisconsin’s latest diabetes study is now endothelial dysfunction. Individuals with Type 2 diabetes on Metformin are encouraged to enroll in this very important paid medical study in Milwaukee. Adults, ages 21 to 80 are eligible, for this study which will evaluate the effect of a diabetic medication on blood vessel function.
The purpose of this study is to find out about a medication commonly used to lower blood sugar with high blood sugar (Type 2 Diabetes). This study is set to be conducted by Dr. Michael Widlansky and will be held throughout the year, the study involves 1 screening visit and 4 visits each 3-5 hours to the research center at the Medical College of Wisconsin, where an assessment of blood vessel function will take place. A stipend will be provided to all participants. All interested individuals are encouraged to contact Allison Couillard via email at acouillard(at)mcw(dot)edu, or by calling 414-805-3148.
The Medical College of Wisconsin is a major national research center, and stands as the largest research institution in the Milwaukee metro area; the 2nd largest in Wisconsin. The Medical College of Wisconsin aims to be a national leader in the education and development of the next generation of physicians and scientists. Every MCW employee strives to discover and translate new knowledge in the biomedical sciences; to provide cutting-edge, interdisciplinary and compassionate clinical care of the highest quality; to improve the health of the communities we serve.